Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy. | Cancer Metastasis Rev | 2023 | 37442876 | PubTator, text mining | PubMed |
| Association Between HTRA1, GAS6 and IFNGR2 Gene Polymorphisms and Stroke Susceptibility in the Chinese Han Population. | Pharmgenomics Pers Med | 2023 | 37441189 | PubTator, text mining | PubMed |
| The covert symphony: cellular and molecular accomplices in breast cancer metastasis. | Front Cell Dev Biol | 2023 | 37440925 | PubTator, text mining | PubMed |
| Emerging roles of noncoding RNAs in human cancers. | Discov Oncol | 2023 | 37439905 | PubTator, text mining | PubMed |
| Relationship between the tumor microenvironment and the efficacy of the combination of radiotherapy and immunotherapy. | Int Rev Cell Mol Biol | 2023 | 37438018 | PubTator, text mining | PubMed |
| Apoptotic bodies: bioactive treasure left behind by the dying cells with robust diagnostic and therapeutic application potentials. | J Nanobiotechnology | 2023 | 37434199 | PubTator, text mining | PubMed |
| Pharmacological profiling identifies divergent chemosensitivities of differentiating and maturing iPSC-derived human cortical neuron populations. | FEBS J | 2023 | 37428551 | PubTator, text mining | PubMed |
| Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy. | Front Cell Dev Biol | 2023 | 37427373 | PubTator, text mining | PubMed |
| Targeting Type I Interferon Induction and Signaling: How Zika Virus Escapes from Host Innate Immunity. | Int J Biol Sci | 2023 | 37416780 | PubTator, text mining | PubMed |
| Diagnostic Efficacy and Possible Underlying Mechanisms of Noninvasive Clinical Markers in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 37408805 | PubTator, text mining | PubMed |
| Genetic and Protein Network Underlying the Convergence of Rett-Syndrome-like (RTT-L) Phenotype in Neurodevelopmental Disorders. | Cells | 2023 | 37408271 | PubTator, text mining | PubMed |
| The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers. | Cells | 2023 | 37408240 | PubTator, text mining | PubMed |
| Declined Serum Resolvin D1 Levels to Predict Severity and Prognosis of Human Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study. | Neuropsychiatr Dis Treat | 2023 | 37396872 | PubTator, text mining | PubMed |
| AXL/Gas6 signaling mechanisms in the hypothalamic-pituitary-gonadal axis. | Front Endocrinol (Lausanne) | 2023 | 37396176 | PubTator, text mining | PubMed |
| Small Extracellular Vesicle-Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma. | Adv Sci (Weinh) | 2023 | 37387563 | PubTator, text mining | PubMed |
| AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells. | Cancer Immunol Res | 2023 | 37378662 | PubTator, text mining | PubMed |
| Real-world experience of cabozantinib in Asian patients with advanced renal cell carcinoma following treatment with VEGFR tyrosine kinase inhibitors and/or immune-checkpoint inhibitors. | Drugs Context | 2023 | 37378080 | PubTator, text mining | PubMed |
| Vitamin K and Hallmarks of Ageing: Focus on Diet and Gut Microbiome. | Nutrients | 2023 | 37375631 | PubTator, text mining | PubMed |
| Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies. | Medicina (Kaunas) | 2023 | 37374319 | PubTator, text mining | PubMed |
| Regulation of PD-L1 Expression by Nuclear Receptors. | Int J Mol Sci | 2023 | 37373038 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=23